Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
2 events,
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Cory Rubin, MD
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Cory Rubin, MD
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years…
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Jason Hawkes, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Jason Hawkes, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in…
2 events,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Justin Greiwe, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Justin Greiwe, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation by Carsten Hamann, MD
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation by Carsten Hamann, MD
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin…
2 events,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Autumn Burnette, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Autumn Burnette, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Brad Glick, DO
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Brad Glick, DO
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Andrew Mastro, PA-C
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Andrew Mastro, PA-C
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin…
2 events,
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Melissa Costner, MD
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Melissa Costner, MD
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years…
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Adam Friedman, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Adam Friedman, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in…
1 event,
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Lakshi Aldredge, NP
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Lakshi Aldredge, NP
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin…
0 events,
0 events,
0 events,
0 events,
1 event,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Dareen Siri, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Dareen Siri, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Kathryn Sowerwine, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Kathryn Sowerwine, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Dareen Siri, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Dareen Siri, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Raffi Tachdjian, MD
A Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Raffi Tachdjian, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.